The serine/threonine kinase, Pim-1, appears to be involved in regulating proliferation, differentiation and cell survival of lymphoid and myeloid cells. In this study, we have found that amino acid residues 140-147 (RKRRQTSM) at the C-terminal end of p21(Cip1/WAF1), a cyclin-dependent kinase (CDK) inhibitor, constitute an ideal phosphorylation consensus sequence for Pim-1. We demonstrate that Pim-1 efficiently phosphorylates this peptide sequence as well as the p21 protein in vitro. We also demonstrate by pull-down assay and by immunoprecipitation that Pim-1 associates with p21. During phorbol ester-induced differentiation of U937 cells, both Pim-1 and p21 expression levels increase with Pim-1 levels increasing in both the nucleus and cytoplasm while p21 remains primarily cytoplasmic. Co-transfection of wild type p21 with wild type Pim-1 results in cytoplasmic localization of p21 while co-transfection of wild type p21 with kinase dead Pim-1 results in nuclear localization of p21. Consistent with the results from the phosphoamino acid assay, Pim-1 phosphorylates transfected p21 only on Thr(145) in p21-deficient human fibroblasts and this phosphorylation event results in the cytoplasmic localization of p21. These findings demonstrate that Pim-1 associates with and phosphorylates p21 in vivo, which influences the subcellular localization of p21.

No abstract

Vascular leak syndrome (VLS) is a harmful side effect that resulted in withdrawal of the antitumor drug FR900482, but not FK317, from clinical trials. Here we present chromatin immunoprecipitation data showing that FK317, like FR900482, crosslinks minor-groove binding proteins to DNA in vivo. However, these drugs differ in how they induce cell death. We demonstrate that, whereas FR900482 induces necrosis, FK317 induces a necrosis-to-apoptosis switch that is drug concentration dependent. Northern blot analyses of drug-treated cells suggest that this "switch" is mediated, at least in part, by modulation of the expression levels of Bcl-2. Additionally, FR900482, in contrast to FK317, induces the expression of known elicitors of both Bcl-2 gene expression and VLS. These findings provide plausible explanations for why these structurally similar drugs have different biological effects, especially with respect to VLS.

Campylobacter jejuni is a leading cause of food-borne disease in developed countries. The goal of this study was to develop a plasmid-based reporter system with green fluorescent protein (GFP) to facilitate the study of C. jejuni in a variety of niches. C. jejuni transformants harboring the pMEK91 GFP gene (gfp)-containing vector were readily detectable by both fluorescence microscopy and flow cytometry. Given the ease of detecting these organisms, additional experiments were performed in which BALB/c mice were injected intraperitoneally with C. jejuni harboring the gfp-containing vector. Four hours after injection of the mice, flow cytometry analyses determined that C. jejuni synthesizing GFP were predominantly associated with granulocytes. More specifically, the proportion of CD11b ؉ Gr-1 ؉ lavage neutrophils with green fluorescence ranged from 99.7 to 100%, while the proportion of CD11b ؉ Gr-1 ؊ lavage macrophages ranged from 77.0 to 80.0%. In contrast, few CD11b ؊ CD45R ؉ B lymphocytes from the lavage of the C. jejuni-injected mice were associated with greenfluorescent C. jejuni (proportions ranged from 0.75 to 0.77%). Cell-free C. jejuni was recovered from tissue homogenates after intraperitoneal injection. Macrorestriction profiling with pulsed-field gel electrophoresis identified a genotypic variant of the C. jejuni F38011 wild-type isolate. In vivo this variant displayed a phenotype identical to that of the wild-type isolate. In summary, we demonstrate that C. jejuni associates with marker-defined cellular subsets in vivo with a novel gfp reporter system and that C. jejuni genotypic variants can be isolated from both in vitro and in vivo systems.

The CD2 molecule is normally expressed on nearly all murine lymphocytes, and is co-stimulatory in T cell activation via the antigen receptor (TCR). A naturally occurring T lymphocyte population that is bimodal for CD2 expression was found in the intestinal intraepithelial lymphocytes (IEL). TCR alpha beta + IEL contain CD2- and CD2+ cells of approximately equal proportion, while TCR gamma delta + IEL are predominantly CD2-. The proliferative response of IEL to stimulation with an anti-CD3 mAb or with PMA plus ionomycin co-segregated with CD2 expression; the CD2+ subset proliferated vigorously under these conditions while the CD2- subset was much less responsive. The responding CD2+ IEL contained both TCR alpha beta + and TCR gamma delta + cells. However, activation of the CD2- IEL with anti-CD3 mAb resulted in only the expansion of TCR gamma delta + IEL, while activation with PMA plus ionomycin did not promote expansion of either the TCR alpha beta + or the TCR gamma delta + IEL. These findings parallel observations in the autoimmune lpr mouse, where massive numbers of peripheral TCR alpha beta + CD4-CD8- T cells that lack CD2 expression are also hyporesponsive to mitogenic stimulation. The apparent anergy of CD2- TCR alpha beta + IEL, as well as CD2- T cells from lpr mice, demonstrates that the absence of CD2 on TCR alpha beta + T lymphocytes co-segregates with nonresponsiveness.

No abstract

Mice depleted of lymphocytes expressing the 4L or the 'yB T-cell receptor for antigen (TCR) by antibody treatment were infected orally with SalmoneUla enteritidis. In both groups of treated mice, the 50% lethal dose decreased, suggesting that both the 41i TCR+ and the y8 TCR+ subsets contribute to resistance to oral infection. These data provide further evidence for the contribution of y8 T cells in the response to bacterial infections.

No abstract